Small Molecules

30 Mar 2007 Arpida announces promising results of "first-in-man" studies with AR-709
30 Mar 2007 Enzon Enrolls First Patient in Phase 1 Study of Its HIF-1 Alpha Antagonist
30 Mar 2007 Hollis-Eden Pharmaceuticals Announces Filing of IND for Phase I Clinical Trial with Next-Generation Drug Candidate HE3286 in Metabolic Disorders
29 Mar 2007 Anesiva Commences Phase 3 Clinical Study of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
29 Mar 2007 Clinical Development Initiated on Lead Compound in NicOx Glaucoma Collaboration with Pfizer
29 Mar 2007 Merck & Co., Inc. and Lundbeck discontinue joint development program for gaboxadol, an investigational compound for insomnia
29 Mar 2007 Dong-A PharmTech Co., Ltd. Announces Positive Results for Udenafil, Its New Long Acting Drug For Erectile Dysfunction
29 Mar 2007 Samaritan Pharma Partners PII HIV Drug to Pharmaplaz; Upfront Payment $10 Million
29 Mar 2007 Portola Pharmaceuticals, Inc. Presents Positive Phase I Data of Its ADP Receptor Antagonist at the American College of Cardiology
28 Mar 2007 Biocryst Pharmaceuticals (BCRX) Places Hold on Trial of IV Leukemia Drug
28 Mar 2007 Barrier Therapeutics, Inc. (BTRX) Announces Azoline (Pramiconazole) Dose Ranging Study in Tinea Versicolor Meets Primary and Secondary Endpoints
28 Mar 2007 AtheroGenics Announces ARISE Phase III Clinical Study Results at the American College of Cardiology's 56th Annual Scientific Session
28 Mar 2007 Horizon Therapeutics Begins Patient Enrollment in Phase 3 Trials for 'GI-Friendly' NSAID
28 Mar 2007 Allon receives approval to begin a Phase II clinical trial for Schizophrenia
28 Mar 2007 Adherex Initiates Combination Trial of ADH-1 and Melphalan for Treatment of Melanoma
28 Mar 2007 CuraGen and TopoTarget Initiate Phase II Trial of Belinostat (PXD101) in Combination with Velcade(R) for Refractory Multiple Myeloma
28 Mar 2007 Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical Data for INO-1001 at ACC Demonstrating PARP Inhibition and Anti-inflammatory Activity in Plasma of Patients Undergoing Primary Percutaneous Coronary Intervention
28 Mar 2007 Myriad Genetics Initiates Phase 2 Clinical Trial of Azixa in Metastatic Brain Cancer
28 Mar 2007 MediciNova Announces Positive Clinical Results From MN-166 Phase II Multiple Sclerosis Trial
27 Mar 2007 Semafore Pharmaceuticals Initiates Phase I Clinical Trial of PI3K Inhibitor SF1126 in Solid Tumor Cancers
27 Mar 2007 Schering-Plough and Merck to Develop Another New Cholesterol Lowering Medicine
27 Mar 2007 Tekturna(R), first new type of high blood pressure medicine in a decade, provides additional blood pressure reduction when used with Diovan(R)
27 Mar 2007 Indevus Reports That Interim Review of NEBIDO(R) Phase III Data Indicates Trial Is Likely to Meet Primary Endpoints
27 Mar 2007 DiObex announces successful completion of phase 2a trial
27 Mar 2007 Ocera Therapeutics Initiates a Phase 2 Trial for Active Pouchitis

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up